Search results
Results From The WOW.Com Content Network
Moderna Inc (NASDAQ: MRNA) is trading lower Monday morning after the U.S. Food and Drug Administration delayed approval of the company's Emergency Use Authorization request for the use of its ...
Moderna's operations burned through $2.7 billion during the 12 months that ended last September, but the company is finally getting a handle on operating expenses that declined significantly in 2024.
In the presentation slides to the U.S. agency, Moderna Inc (NASDAQ:MRNA) shared safety set data, with a cut-off date of March 8, 2024, based on the median of 18.8 months of follow-up.
The stock is trying to settle below $325. For premium support please call: 800-290-4726 more ways to reach us
The stock made an attempt to settle below $221. For premium support please call: 800-290-4726 more ways to reach us
For premium support please call: 800-290-4726 more ways to reach us
Moderna held its annual R&D day this week. Home & Garden. Lighter Side
For premium support please call: 800-290-4726 more ways to reach us